CD4 and breast cancer: We found that CD177+ or CD177− TI Treg cells, defined as CD4+CD25+CD127low, from human cancer specimens exhibited a similar level of FOXP3 protein in 1 breast cancer, 2 colon cancers and 3 ccRCCs (Supplementary Fig. 9b).